GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 69 filers reported holding GENERATION BIO CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,081 | -31.1% | 2,660 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $14,630 | +21.4% | 2,660 | -13.3% | 0.00% | 0.0% |
| Q4 2022 | $12,053 | +142.3% | 3,067 | +227.3% | 0.00% | – |
| Q3 2022 | $4,975 | -75.1% | 937 | -69.2% | 0.00% | -100.0% |
| Q2 2022 | $19,982 | -10.6% | 3,046 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $22,358 | -68.8% | 3,046 | -69.9% | 0.00% | 0.0% |
| Q4 2021 | $71,699 | -76.1% | 10,127 | -15.5% | 0.00% | -75.0% |
| Q3 2021 | $300,414 | -7.4% | 11,983 | +5.1% | 0.00% | -20.0% |
| Q1 2021 | $324,586 | +197.5% | 11,405 | +196.4% | 0.01% | +150.0% |
| Q4 2020 | $109,091 | -8.3% | 3,848 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $118,942 | – | 3,848 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |